is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The CPhI Japan team has been working hard to actively monitor the COVID-19 situation and as it stands, we do not plan to further postpone or cancel our event, which will take place on the rescheduled dates of 30 September – 2 October 2020.
The wellbeing of our community remains our top priority and as an Organized Gathering we will be implementing the World Health Organization’s recommended measures for gatherings, as well as following the steps advised by local health authorities.
As restrictions are lifted, we will have a better idea of the best-in-class biosecurity measures that we can adopt, as well as the alternative models that will best serve our community, with your wellbeing at the heart of our decision making.
We will continue to keep you updated as we learn more and formulate plans to ensure that CPhI Japan remains the go-to event for the Japanese pharmaceutical industry.
The CPhI Japan team thanks you for your continued support and understanding during this time.
This report highlights trends in Japan’s pharma market, notably how costly, long-listed products will be replaced due to generic and biosimilar industries continuing to grow in volume and market share. It also discusses increased internationalisation of innovation, with a rise in acquisitions and partnerships with academia.
Global Pharma Insights is a new dedicated platform providing news, features, interviews and in-depth analysis on issues impacting pharmaceutical supply chains. From drug discovery and development to manufacturing and delivery, we bring you impactful content to keep you informed and help drive your business forward.